Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Rang in Aktien #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Aktienkurs
$1.50
Zuletzt synchronisiert: 2026-09-21
Marktkapitalisierung
$3.63M
Veränderung (1 Tag)
-4.46%
Veränderung (1 Jahr)
-72.68%
Land
MY
Handel BioNexus Gene Lab Corp. (BGLC)

Kategorie

P/B-Verhältnis für BioNexus Gene Lab Corp. (BGLC)
P/B-Verhältnis zum September 2026 TTM: 0.47
Laut den neuesten Finanzberichten und dem Aktienkurs von BioNexus Gene Lab Corp. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0.47. Am Ende des Jahres 2023 lag das P/B-Verhältnis bei 0.95.
P/B-Verlauf für BioNexus Gene Lab Corp. von 2016 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) 0.47 -22.30%
2024 0.60 -36.56%
2023 0.95 -96.17%
2022 24.65 -51.50%
2021 50.81 49.46%
2020 34.00 -79.93%
2019 169.36 76.55%
2018 95.93 -94.47%
2017 1.74K -101.39%
2016 -125.28K 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
14.6275 3,037.60%
US
13.9445 2,891.10%
US
- -
US
3.1438 574.35%
US
- -
US